These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23749409)

  • 1. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
    Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
    Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
    Richter K; Oxenius A
    Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent.
    Richter K; Perriard G; Oxenius A
    Eur J Immunol; 2013 Mar; 43(3):649-54. PubMed ID: 23348876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual LCMV antigen in transiently CD4
    Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
    Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
    Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
    Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
    Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
    Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
    Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
    J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
    Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.